Pfizer Inc. (NYSE: PFE) recently announced that it has entered into definitive agreement with ICU Medical (NASDAQ: ICUI) to sell its infusion systems business, which it had received via the acquisition of Hospira last year.
Pfizer Inc. (NYSE:PFE) fell -0.94% during previous trade. Jefferies issued rating on the stock of Pfizer Inc. (NYSE:PFE) in a research note issued to investors on Oct-13-16, the stock received “Downgrade” rating from Buy to Hold.
NEW YORK Pfizer Inc (PFE.N), which was considering splitting itself for more than two years, said on Monday it would not do so, prompting shareholders to expect more deals that could bolster its roster of new medicines.
Pfizer Inc. (NYSE:PFE) reported its last earnings on Jun 16 . The company will report its next earnings on 1-Nov-16. The company reported the earnings of $0.64/Share in the last quarter where the estimated EPS by analysts was $0.62/share.